SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-122414
Filing Date
2023-11-30
Accepted
2023-11-30 16:04:02
Documents
10
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2331692d1_6k.htm 6-K 12258
2 EXHIBIT 5.1 tm2331692d1_ex5-1.htm EX-5.1 26238
3 EXHIBIT 10.1 tm2331692d1_ex10-1.htm EX-10.1 241936
4 EXHIBIT 99.1 tm2331692d1_ex99-1.htm EX-99.1 13096
5 GRAPHIC tm2331692d1_ex99-2img007.jpg GRAPHIC 7024
6 GRAPHIC tm2331692d1_ex99-2img005.gif GRAPHIC 3765
7 GRAPHIC tm2331692d1_ex99-2img003.jpg GRAPHIC 2165
8 GRAPHIC tm2331692d1_ex99-2img002.jpg GRAPHIC 3361
9 GRAPHIC tm2331692d1_ex5-1img002.jpg GRAPHIC 2811
10 GRAPHIC tm2331692d1_ex5-1img001.jpg GRAPHIC 31114
  Complete submission text file 0001104659-23-122414.txt   364742
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 231455696
SIC: 2834 Pharmaceutical Preparations